


China Medical System Holdings
Pharmaceutical Manufacturing • Nanshan District, Guangdong, China • 201-500 Employees
Company overview
| Headquarters | 6/F, 8/F, Build. A, Tongfang Info. Harb. No. 11 Langshan Road, Nanshan District Hi-tech Park North Zone, Shenzhen , GD | Guangdong 518057, CN |
| Phone number | +8675582416868 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 1995 |
| Employees | 201-500 |
Key Contacts at China Medical System Holdings
Sampson Lau
Director Of Investment And Bd
Ziye Shen
Bd Director
Gisele Wang
Compliance Director
China Medical System Holdings Email Formats
China Medical System Holdings uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 54.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 54.7% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 19.2% |
{last name}.{first name}@company.com | doe.john@company.com | 11.3% |
{first name}@company.com | john@company.com | 9.1% |
{first name}{last name}@company.com | johndoe@company.com | 5.7% |
About China Medical System Holdings
China Medical System Holdings Limited (“CMS”, together with its subsidiaries, the “Group”) is a well-established, innovation-driven specialty pharma with a focus on sales and marketing in China, dedicated to offering competitive products and services to meet China's unmet needs for health and beauty. Since 28 September 2010, the Group has been listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 867), and included in the Morgan Stanley Capital International (MSCI) China Index, Hang Seng Healthcare Index, etc. The Group is the object of transaction in both Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, and also the largest shareholder of Tibet Rhodiola Pharmaceutical Holding Co. (stock code: 600211), a company listed on Shanghai Stock Exchange (A-share). The Group focuses on innovative products that are global first-in-class, or with the best efficacy, safety or cost-effectiveness in the class due to their innovative formulations or drug delivery systems, and has built an innovative product pipeline with relatively high innovation level, good market potential and competitive differentiation advantages. Meanwhile, the Group has proven and successful experience in drug commercialization and strong capability in professional academic promotion, having created a leading market position for many existing drugs and facilitated the clinical development of innovative drugs in China.
China Medical System Holdings revenue & valuation
| Annual revenue | $24,500,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $78,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
China Medical System Holdings has 30 employees across 12 departments.
Departments
Number of employees
Funding Data
China Medical System Holdings has never raised funding before.
Frequently asked questions
4.8
40,000 users



